Clinical trial
Total XV - Total Therapy Study XV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
NCT00137111 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Total XV - Total Therapy Study XV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
- Lead sponsor
- St. Jude Children's Research Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 8, 2000
- Completion date
- April 30, 2014
- Enrollment
- 501 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
lymphoblastic leukemia, acute